Non Invasive Fat Reduction Market
Non Invasive Fat Reduction Market - Global Industry Assessment & Forecast
- By Technology Cryolipolysis, Ultrasound, Low Level Lasers, Others
- By End-Use Hospitals, Stand Alone Practices, Multispecialty Clinics, Others
- By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
|Forecast Years:||2021 - 2028|
|Historical Years:||2016 - 2020|
|Revenue 2021:||USD 579.2 Million|
|Revenue 2028:||USD 1903.2 Million|
|Revenue CAGR (2021 - 2028):||16.9%|
|Fastest Growing Region (2021 - 2028)||Asia Pacific|
|Largest Region (2021):||North America|
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
Global Non Invasive Fat Reduction market is valued at USD 579.2 Million in 2021 and is projected to attain a value of USD 1903.2 Million by 2028 at a CAGR of 16.9% during the forecast period, 2022–2028. Non-invasive fat reduction is a non-surgical fat reduction aesthetic process that uses cryolipolysis, radiofrequency, and laser lipolysis to reduce or eradicate persistent fat pockets in specific parts of the body. The FDA has approved the devices used in these treatments to permanently eliminate fat cells because they have been studied for efficiency and safety, and the findings have been confirmed to show significant results. These therapies must be performed by qualified professionals who are technically proficient. CoolSculpting, Kybella, Vanquish, and Sculpsure are some of the most well-known non-invasive fat reduction brands.
Non Invasive Fat Reduction Market Size, 2021 To 2028 (USD Million)
The COVID-19 pandemic has wreaked havoc on the global population and economy. Across the globe, the COVID-19 pandemic caused substantial obstacles to the health-care system. Due to the imposition of lockdown, which resulted in trade restrictions and supply chain disruptions, it had a negative impact on the growth of the surgical apparel market for a short period of time. In addition, many non-essential medical and surgical treatments were halted, which had an impact on market growth.
Rise in Healthcare Expenditure
According to the World Health Organization, a sedentary lifestyle is a primary contributor to obesity, sickness, and disability. Obesity is responsible for over 2.0 million deaths per year. Physical inactivity, sedentary and long work hours, and behavioral risk factors such as alcohol drinking, smoking, and stress are all contributing to an unhealthy lifestyle, which has resulted in diseases such as diabetes and obesity. People currently have less time to focus on their physical health as a result of urbanization, and they seek for alternative methods to combat or eliminate stubborn fat. Increased acceptance and demand for body contouring procedures, as well as an increase in health-care spending and an increase in the prevalence of obesity, are driving the expansion of the non-invasive fat reduction industry.
High Cost Involved in the Research and Development
The high cost of obesity drug research and development, along with limited financial assistance, pose a significant impediment to the obesity management market's growth. Furthermore, longer research and development efforts, as well as the inclusion of clinical trials to evaluate pharmaceuticals, raise overall costs. As a result, given the current situation, producers must exercise caution and ensure that they invest in markets that deliver a higher return on investment.
The risks and constraints posed by obesity medications' high development costs could stifle worldwide market expansion. Due to the high cost of surgical procedures such as gastric bypass, adjustable gastric banding, gastric sleeve surgery, and intragastric balloon treatment, non-invasive fat reduction technologies are becoming more popular.
The Non Invasive Fat Reduction market scope can be tabulated as below:
The Global Non Invasive Fat Reduction Market has been segmented by Technology into Cryolipolysis, Ultrasound, Low Level Lasers and Others. Based on End-Use into Hospitals, Stand, Alone Practices, Multi-specialty Clinics and Others. Based on Region, the Non Invasive Fat Reduction Market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Below tree is interactive. You can click the nodes to get more information.
North America to Continue Dominating the Non Invasive Fat Reduction Market
North America, Europe, and Asia Pacific accounted for the greatest proportion of the Non Invasive Fat Reduction market in 2021. Factors such as the increase in the number of well-established Non Invasive Fat Reduction companies and research institutes in the United States and Canada, a large number of ongoing research studies, and the overall growth of the healthcare sector on a global scale are among the few factors expected to contribute to the market's growth. The regional market growth can be attributed to expanding geriatric populace, increasing surgical procedures, expanding and presence of established healthcare infrastructure. One of the primary causes leading to the growing demand for Non Invasive Fat Reduction techniques and technologies among academic and research organisations, as well as healthcare firms in North America, is increased R&D spending.
Key participants operating in the Non Invasive Fat Reduction market are: Cutera Inc (US), Hologic Inc (US), Candela Corporation (US), Bausch Health Companies (Canada), Alma Lasers (Israel) are the major companies operating in Non-Invasive Fat Reduction Market.
The Non Invasive Fat Reduction market is segmented as follows:
Regions & Countries Covered
Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST
analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market
attractiveness analysis by segments and North America, company market share analysis, and COVID-19
Frequently Asked Question
What is the global demand for Non Invasive Fat Reduction in terms of revenue?
The global Non Invasive Fat Reduction valued at in 2020 and is expected to reach in 2028 growing at a CAGR of 16.9%.
Which are the prominent players in the market?
The prominent players in the market are Cutera Inc (US), Hologic Inc (US), Candela Corporation (US), Bausch Health Companies (Canada), Alma Lasers (Israel) are the major companies operating in Non-Invasive Fat Reduction Market..
At what CAGR is the market projected to grow within the forecast period?
The market is project to grow at a CAGR of 16.9% between 2021 and 2028.
What are the driving factors fueling the growth of the market.
The driving factors of the Non Invasive Fat Reduction include
- Rise in Healthcare Expenditure
Which region accounted for the largest share in the market?
North America was the leading regional segment of the Non Invasive Fat Reduction in 2020.